{{Rsnum
|rsid=1333026
|Chromosome=13
|position=65546652
|Orientation=plus
|GMAF=0.1373
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 25.9 | 71.4
| HCB | 0.0 | 14.8 | 85.2
| JPT | 0.9 | 12.4 | 86.7
| YRI | 9.5 | 42.9 | 47.6
| ASW | 7.0 | 43.9 | 49.1
| CHB | 0.0 | 14.8 | 85.2
| CHD | 0.0 | 15.7 | 84.3
| GIH | 0.0 | 14.9 | 85.1
| LWK | 4.6 | 37.0 | 58.3
| MEX | 1.8 | 17.5 | 80.7
| MKK | 9.7 | 31.6 | 58.7
| TSI | 0.0 | 22.5 | 77.5
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs1333026
|PubMedID=17903300
|Condition=BMI
|Gene=Intergenic
|Risk Allele=
|pValue=8.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1333026
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903300; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project (Initial Sample Size: 1,341 individuals (Framingham); Replication Sample Size: NR). This variant is associated with BMI.
|Drugs=
|Drug Classes=
|Diseases=Obesity
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356520
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1333026
|overall_frequency_n=98
|overall_frequency_d=120
|overall_frequency=0.816667
|n_genomes=49
|n_genomes_annotated=0
|n_haplomes=85
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}